Company
Headquarters: Bangkok, Thailand
CEO: Dr. Trinnawat Thanitnithiphan
฿2.99 Billion
THB as of July 1, 2024
US$81.5 Million
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $622.07 B |
Vertex Pharmaceuticals Incorporated | $121.36 B |
Regeneron Pharmaceuticals, Inc. | $115.11 B |
CSL Limited | $95.75 B |
Marinomed Biotech AG | $75.67 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Inter Pharma Public Company Limited develops, produces, and sells healthcare products in Thailand. It operates through two segments, Human Healthcare and Animal Healthcare. The company offers human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary foods, probiotic and prebiotic products, health food products, general food products, medical equipment and medicines, etc.; a range of wellness and anti-aging products; aesthetic products, such as anti-wrinkle creams, hyaluronic fillers, and EGF cosmeceuticals; and diagnostic products, including blood group tests and cool box systems. It also provides pet healthcare and livestock products comprising medical supplies, nutrition therapy, vaccines, supplementary foods, probiotic and prebiotic products, animal health food products, premium grade animal foods, general formula animal foods, etc., as well as medical equipment related to pet and livestock care products. In addition, the company imports and distributes dietary supplement products for humans and animals. The company was founded in 2006 and is headquartered in Bangkok, Thailand.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Inter Pharma Public Company Ltd has the following listings and related stock indices.
Stock: SET: IP wb_incandescent
Stock: SET: IP.R wb_incandescent